Advances in diagnostic testing for Alzheimer disease.

Suzanne E. Schindler; Jonathan McConathy; Beau M. Ances; Marc I. Diamond

Advances in diagnostic testing for Alzheimer disease.

Suzanne E. Schindler, Jonathan McConathy, Beau M. Ances, Marc I. Diamond

Research output: Contribution to journal › Review article › peer-review

Abstract

The diagnosis of Alzheimer disease (AD) dementia is based primarily on the clinical history and examination, but advances in understanding the pathophysiology of AD have led to new diagnostic methods. When used appropriately, the tests can provide strong positive or negative evidence AD dementia. This article described which patients may benefit from additional testing using Cerebrospinal Fluid (CSF) biomarkers, amyloid imaging, quantitative structural magnetic resonance imaging (MRI), and fluoro-deoxyglucose positron emission tomography (FDG-PET).

Original language	English
Pages (from-to)	401-405
Number of pages	5
Journal	Missouri Medicine
Volume	110
Issue number	5
State	Published - Jan 1 2013

Cite this

@article{0d22079377a545918d3359a18c5b464a,

title = "Advances in diagnostic testing for Alzheimer disease.",

abstract = "The diagnosis of Alzheimer disease (AD) dementia is based primarily on the clinical history and examination, but advances in understanding the pathophysiology of AD have led to new diagnostic methods. When used appropriately, the tests can provide strong positive or negative evidence AD dementia. This article described which patients may benefit from additional testing using Cerebrospinal Fluid (CSF) biomarkers, amyloid imaging, quantitative structural magnetic resonance imaging (MRI), and fluoro-deoxyglucose positron emission tomography (FDG-PET).",

author = "Schindler, {Suzanne E.} and Jonathan McConathy and Ances, {Beau M.} and Diamond, {Marc I.}",

year = "2013",

month = jan,

day = "1",

language = "English",

volume = "110",

pages = "401--405",

journal = "Missouri Medicine",

issn = "0026-6620",

number = "5",

}

TY - JOUR

T1 - Advances in diagnostic testing for Alzheimer disease.

AU - Schindler, Suzanne E.

AU - McConathy, Jonathan

AU - Ances, Beau M.

AU - Diamond, Marc I.

PY - 2013/1/1

Y1 - 2013/1/1

N2 - The diagnosis of Alzheimer disease (AD) dementia is based primarily on the clinical history and examination, but advances in understanding the pathophysiology of AD have led to new diagnostic methods. When used appropriately, the tests can provide strong positive or negative evidence AD dementia. This article described which patients may benefit from additional testing using Cerebrospinal Fluid (CSF) biomarkers, amyloid imaging, quantitative structural magnetic resonance imaging (MRI), and fluoro-deoxyglucose positron emission tomography (FDG-PET).

AB - The diagnosis of Alzheimer disease (AD) dementia is based primarily on the clinical history and examination, but advances in understanding the pathophysiology of AD have led to new diagnostic methods. When used appropriately, the tests can provide strong positive or negative evidence AD dementia. This article described which patients may benefit from additional testing using Cerebrospinal Fluid (CSF) biomarkers, amyloid imaging, quantitative structural magnetic resonance imaging (MRI), and fluoro-deoxyglucose positron emission tomography (FDG-PET).

UR - http://www.scopus.com/inward/record.url?scp=84891650982&partnerID=8YFLogxK

M3 - Review article

C2 - 24279191

AN - SCOPUS:84891650982

SN - 0026-6620

VL - 110

SP - 401

EP - 405

JO - Missouri Medicine

JF - Missouri Medicine

IS - 5

ER -

Advances in diagnostic testing for Alzheimer disease.

Abstract

Other files and links

Fingerprint

Cite this